Pharmacokinetics of testosterone therapies in relation to diurnal variation of serum testosterone levels as men age

Autor: James P Tursi, Jonathan S. Jaffe, David Schofield, Marc Gittelman, Martin Miner, Alexander W. Pastuszak

Publikováno v: Andrology. 10(2)

Background To improve symptoms associated with testosterone deficiency, many testosterone therapies are available that aim to restore serum testosterone (T) levels to the normal physiologic range. The magnitude, frequency, and duration between peak a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc5083669d1b46e1671b56a43aa18fa2
https://pubmed.ncbi.nlm.nih.gov/34510812

SAT-037 Effect of Weight on Serum Testosterone with Subcutaneous Testosterone Enanthate in Men with Testosterone Deficiency

Autor: Jonathan S. Jaffe, Rajib K. Bhattacharya, James P. Tursi

Publikováno v: Journal of the Endocrine Society

BACKGROUND: In men, obesity is often associated with low testosterone (T) levels, but information is limited as to how body weight affects the pharmacokinetic profile or dosing of testosterone therapy (TTh) in men with T deficiency. Historically, men

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5663b3405ebc1a1dc90446a2633cd4d5
https://doi.org/10.1210/jendso/bvaa046.454

MP58-19 IMPACT OF WEEKLY SUBCUTANEOUS TESTOSTERONE ENANTHATE ON BLOOD PRESSURE IN A 26-WEEK SAFETY STUDY

Autor: Jonathan S. Jaffe, Martin Miner, Marc Gittelman, James P. Tursi, Mohit Khera, Jed Kaminetsky, Alexander W. Pastuszak

Publikováno v: Journal of Urology. 201

INTRODUCTION AND OBJECTIVES:The Subcutaneous Testosterone Enanthate Auto-Injector (SCTE-AI) has been designed to safely deliver testosterone (T) by allowing patients with T deficiency to self-admin...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d0610f9c29cd97cc7f0e8a8baa7aa73c
https://doi.org/10.1097/01.ju.0000556711.64543.28

The Efficacy and Safety of Concurrent Collagenase Clostridium Histolyticum Injections for 2 Dupuytren Contractures in the Same Hand: A Prospective, Multicenter Study

Autor: Brian Dean, Lawrence C. Hurst, R. Glenn Gaston, Søren Larsen, Stephen Coleman, James P. Tursi, Gary M. Pess, Gregory J. Kaufman, Brian M. Cohen

Publikováno v: Gaston, R G, Larsen, S, Pess, G M, Coleman, S, Dean, B, Cohen, B M, Kaufman, G J, Tursi, J P & Hurst, L C 2015, ' The Efficacy and Safety of Concurrent Collagenase Clostridium Histolyticum Injections for 2 Dupuytren Contractures in the Same Hand : A Prospective, Multicenter Study ', Journal of Hand Surgery (American Volume), vol. 40, no. 10, pp. 1963-1971 . https://doi.org/10.1016/j.jhsa.2015.06.099

Purpose To evaluate efficacy and safety of concurrent administration of 2 collagenase clostridium histolyticum (CCH) injections to treat 2 joints in the same hand with Dupuytren fixed flexion contractures (FFCs). Methods Patients with 2 or more contr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::434765247ef83a59e13da198e960574c
https://doi.org/10.1016/j.jhsa.2015.06.099

The budget impact of using enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg to prevent recurrent cardiovascular events

Autor: Wenjie Zhang, James P Tursi, Yi Han, David Schofield, John G Fort

Publikováno v: Journal of medical economics. 20(6)

Aspirin (acetylsalicylic acid; ASA) is commonly used for secondary prevention of cardiovascular (CV) events, but may be associated with gastrointestinal (GI) adverse events, which can reduce adherence. Use of ASA co-therapy with proton pump inhibitor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea0452bb820735194e959ed5eb2f8ae4
https://pubmed.ncbi.nlm.nih.gov/28145783